AI Terminal

MODULE: AI_ANALYST

Interactive Q&A, Risk Assessment, Summarization

MODULE: DATA_EXTRACT

Excel Export, XBRL Parsing, Table Digitization

MODULE: PEER_COMP

Sector Benchmarking, Sentiment Analysis

SYSTEM ACCESS LOCKED

Authenticate / Register Log In

Sopharma AD

Proxy Solicitation & Information Statement • Mar 26, 2021

2543_rns_2021-03-26_be91deda-942a-450a-8555-25379fcb6d4a.pdf

Proxy Solicitation & Information Statement

Open in Viewer

Opens in native device viewer

Current report №9 / 2021 Dated March 26, 2021

NOTIFICATION

Sopharma AD invites all shareholders of the Company to exercise their voting right on the announced agenda items of the Extraordinary General Meeting convened for 2 April 2021 from 11:00 a.m. (8:00 a.m.) through correspondence. In an effort to preserve the normal operation of all the bodies of "Sopharma" AD and at the same time not to jeopardize the health of the interested parties in the conditions of a pandemic, the Board of Directors provide an opportunity for shareholders to exercise their voting rights in advance. The rules for voting by correspondence are described in detail in the invitation to convene the General Meeting. A sample declaration for voting by correspondence is attached to it.

Signatures of individuals authorized to represent the Company:

Ognian Donev